3.08 USD
↘ 0.09 (2.69%)AT CLOSE (11:59 AM EDT)
Acumen Pharmaceuticals, Inc. Common Stock
ABOSNASDAQ • USD
3.16
↗ 0.08 (2.76%)
POST MARKET (AS OF 07:53 PM EDT)
Post Market
AS OF 07:53 PM EDT
3.16
↗ 0.08 (2.76%)
Market: CLOSED
Shares of Acumen Pharmaceuticals, Inc. Common Stock (ABOS) are trading at $3.08. ABOS shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, ABOS trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 24, 2026.
Open?$3.17
High?$3.17
Low?$3.04
Prev. Close?$3.16
Volume?276.0K
Avg. Volume?387.5K
VWAP?$3.10
Rel. Volume?0.71x
Bid / Ask
Bid?$3.02 × 100
Ask?$3.28 × 500
Spread?$0.26
Midpoint?$3.15
Valuation & Ratios
Market Cap?222.7M
Shares Out?72.3M
Float?37.4M
Float %?51.8%
P/E Ratio?N/A
P/B Ratio?3.89
EPS?-$1.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Employees
61
Market Cap
228.5M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-07-01
Address
1210-1220 WASHINGTON STREET
NEWTON, MA 02465
Phone: 617-344-4190
NEWTON, MA 02465
Phone: 617-344-4190
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?44
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.05Distress
Confidence?44%Low
Short InterestHigh
Short % of Float?9.00%Elevated
Short Interest?3.4M
Days to Cover?9.5
Free Float37.4M
Avg Daily Volume355.8K
Settlement Date2026-07-31
Financial Health
Current Ratio?2.47Strong
Quick Ratio?2.47Strong
Cash Ratio?1.27Strong
Debt/Equity?0.55Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?3.89FAIR▾
Peers100
S&P45
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-183.4%WEAK▾
S&P3
ROA?-90.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-91788000
Enterprise Value?$194.9M
Fundamentals ratios updated end of day